Authors:
NISIPEANU P
INZELBERG R
BLUMEN SC
CARASSO RL
HATTORI N
MATSUMINE H
MIZUNO Y
Citation: P. Nisipeanu et al., FAMILIAL PARKINSONS-DISEASE IN A JEWISH YEMENITE KINDRED - LINKAGE TOTHE LOCUS FOR AUTOSOMAL RECESSIVE JUVENILE PARKINSONISM, Annals of neurology, 44(3), 1998, pp. 62-62
Citation: P. Nisipeanu et T. Grunebaum, THE RUHRVERBAND - A WATER MANAGEMENT ASSOCIATION FOR AN ENTIRE CATCHMENT-AREA BASED ON A SPECIAL ACT, AQUA, 47(5), 1998, pp. 229-235
Authors:
BLUMEN SC
NISIPEANU P
MERDER R
INZELBERG R
CARASSO RP
Citation: Sc. Blumen et al., THE REVERSIBLE POSTERIOR LEUKOENCEPHALOPATHY SYNDROME PRESENTING AS HOMONYMOUS HEMIANOPIA WITH EPILEPTIC VISUAL HALLUCINATIONS AFTER KETOACIDOTIC COMA, Neurology, 48(3), 1997, pp. 6063-6063
Citation: Ad. Korczyn et P. Nisipeanu, SAFETY PROFILE OF COPOLYMER-1 - ANALYSIS OF CUMULATIVE EXPERIENCE IN THE UNITED-STATES AND ISRAEL, Journal of neurology, 243(4), 1996, pp. 23-26
Authors:
INZELBERG R
NISIPEANU P
RABEY JM
ORLOV E
CATZ T
KIPPERVASSER S
SCHECHTMAN E
KORCZYN AD
Citation: R. Inzelberg et al., DOUBLE-BLIND COMPARISON OF CABERGOLINE AND BROMOCRIPTINE IN PARKINSONS-DISEASE PATIENTS WITH MOTOR FLUCTUATIONS, Neurology, 47(3), 1996, pp. 785-788
Authors:
INZELBERG R
NISIPEANU P
RABEY MJ
KORCZYN AD
Citation: R. Inzelberg et al., LONG-TERM TOLERABILITY AND EFFICACY OF CABERGOLINE, A NEW LONG-ACTINGDOPAMINE AGONIST, IN PARKINSONS-DISEASE, Movement disorders, 10(5), 1995, pp. 604-607
Authors:
INZELBERG R
NISIPEANU P
RABEY JM
KATZ T
ORLOV Y
KIPERVASSER S
SCHECHTMAN E
KORCZYN AD
Citation: R. Inzelberg et al., COMPARISON OF CARBERGOLINE (CBG) AND BROMOCRIPTINE (BCR) IN PARKINSONS-DISEASE (PD) PATIENTS WITH MOTOR FLUCTUATIONS, Neurology, 45(4), 1995, pp. 292-292
Authors:
BOKSTEIN F
NEUFELD MY
NISIPEANU P
KORCZYN AD
Citation: F. Bokstein et al., PAINFUL PAROXYSMAL DYSTONIA ASSOCIATED WITH FOCAL EPILEPTIC ACTIVITY, Journal of Neurology, Neurosurgery and Psychiatry, 58(2), 1995, pp. 257-258